Dietary glycation compounds - implications for human health

• Published in: Critical reviews in toxicology 2024-09, Vol.54 (8), p.485-617
• Main Authors: Hellwig, Michael, Diel, Patrick, Eisenbrand, Gerhard, Grune, Tilman, Guth, Sabine, Henle, Thomas, Humpf, Hans-Ulrich, Joost, Hans-Georg, Marko, Doris, Raupbach, Jana, Roth, Angelika, Vieths, Stefan, Mally, Angela
• Format: Article
• Language: English
• Subjects: Animals; Diet; Glycation End Products, Advanced - metabolism; Glycation End Products, Advanced - toxicity; Humans; Maillard Reaction
• ISSN: 1040-8444; 1547-6898; 1547-6898
• DOI: 10.1080/10408444.2024.2362985

The term "glycation compounds" comprises a wide range of structurally diverse compounds that are formed endogenously and in food the Maillard reaction, a chemical reaction between reducing sugars and amino acids. Glycation compounds produced endogenously are considered to contribute to a range of diseases. This has led to the hypothesis that glycation compounds present in food may also cause adverse effects and thus pose a nutritional risk to human health. In this work, the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG) summarized data on formation, occurrence, exposure and toxicity of glycation compounds (Part A) and systematically assessed potential associations between dietary intake of defined glycation compounds and disease, including allergy, diabetes, cardiovascular and renal disease, gut/gastrotoxicity, brain/cognitive impairment and cancer (Part B). A systematic search in Pubmed (Medline), Scopus and Web of Science using a combination of keywords defining individual glycation compounds and relevant disease patterns linked to the subject area of food, nutrition and diet retrieved 253 original publications relevant to the research question. Of these, only 192 were found to comply with previously defined quality criteria and were thus considered suitable to assess potential health risks of dietary glycation compounds. For each adverse health effect considered in this assessment, however, only limited numbers of human, animal and studies were identified. While studies in humans were often limited due to small cohort size, short study duration, and confounders, experimental studies in animals that allow for controlled exposure to individual glycation compounds provided some evidence for impaired glucose tolerance, insulin resistance, cardiovascular effects and renal injury in response to oral exposure to dicarbonyl compounds, albeit at dose levels by far exceeding estimated human exposures. The overall database was generally inconsistent or inconclusive. Based on this systematic review, the SKLM concludes that there is at present no convincing evidence for a causal association between dietary intake of glycation compounds and adverse health effects.